Dr. David Leahy
Dr. David K. Leahy
Is a Principal Scientist in Chemical and Synthetic Development at Bristol-Myers Squibb with over 12 years of experience leading multidisciplinary preclinical to Phase 3 R&D projects. He obtained his PhD at Indiana University studying rhodium-catalyzed allylic substitutions. David is one of the Green Chemistry and Sustainability leaders at Bristol-Myers Squibb, and a past co-chair of the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable.